RT Journal Article
SR Electronic
T1 Predicting In-hospital Mortality Using Elixhauser Comorbidity in Patients Underwent Single and Multiple Coronary Artery Bypass Surgery
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.02.23288050
DO 10.1101/2023.04.02.23288050
A1 Li, Renxi
YR 2023
UL http://medrxiv.org/content/early/2023/04/10/2023.04.02.23288050.abstract
AB Background Coronary Artery Bypass Graft (CABG) surgery is a high-risk surgery (mortality rate between 2-4 percent) performed in patients with ischemic heart disease (IHD). Cardiovascular diseases are strongly associated with comorbidities. This study aimed to assess the prediction of in-hospital mortality by comorbidities in patients who underwent single, double, triple, or quadruple and more CABG.Methods The National Inpatient Sample (NIS) database was used to extract patients who received 1, 2, 3, or 4+ CABG between the last quarter of 2015 and 2020. Best-fit model by logistic regressions was used to predict in-hospital mortality by Elixhauser Comorbidity Index (ECI). Moreover, age was adjusted in ECI prediction.Results In-hospital mortality was best predicted by ECI in patients who underwent 3 CABG (c-statistic = 0.6325, 95% CI = 0.6151-0.6499), followed by 4+ CABG (c-statistic = 0.6308, 95% CI = 0.5997-0.6620), 1 CABG (c-statistic = 0.6194, 95% CI = 0.6108-0.6281), and 2 CABG (c-statistic = 0.6193, 95% CI = 0.6069-0.6317). After adjusting for age, ECI adequately predicted in-hospital mortality in 4+ CABG (c-statistic = 0.7196, 95% CI = 0.6916-0.7477) and 3 CABG (c-statistic = 0.6937, 95% CI = 0.6774-0.7101). The predictive power for age-adjusted ECI was comparable in 1 CABG (c-statistic = 0.6674, 95% CI = 0.6594-0.6755) and 2 CABG (c-statistic = 0.6664, 95% CI = 0.6549-0.6780).Conclusions This study showed that ECI alone was a moderate (c-statistic 0.6-0.7) predictor of in-hospital mortality in all CABG. Age-adjusted ECI could effectively predict in-hospital mortality, especially in patients who underwent 3 and 4+ CABG.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of The George Washington University waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.AUCarea under curveCABGCoronary Artery Bypass GraftCIconfidence intervalECIElixhauser Comorbidity IndexICD-10-CMInternational Classification of Diseases, Tenth Revision, Clinical ModificationICD-10-PCSInternational Classification of Diseases, Tenth Revision, Procedure Coding SystemIHDischemic heart diseaseNISNational (Nationwide) Inpatient SampleROCreceiver operating characteristic